微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.81% | -49.3% | 2.26% | 65/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 1.77% | -34.44% | -62.58% | 47/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 4.73% | 27.49% | -1.25% | 57/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 4.79% | -8.24% | 34.17% | 59/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 3.57% | 0% | 32.22% | 47/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 2.7% | -1.1% | -27.22% | 27/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 3.71% | -38.98% | -28.93% | 70/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 5.22% | -35.87% | 46.22% | 51/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 3.57% | -35.09% | 30.77% | 57/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 2.73% | -38.65% | -55.1% | 34/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 6.08% | 111.63% | -25.31% | 67/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 8.14% | 123.52% | 48% | 42/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 5.5% | 114.41% | 23.6% | 41/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 4.45% | 62.41% | 108.52% | 21/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | -52.26% | -874.22% | -51% | 129/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | -34.61% | -539.77% | 9.35% | 118/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | -38.18% | -998.35% | -1493.43% | 124/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 2.74% | 10.93% | -59.41% | 59/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 6.75% | 42.11% | -14.23% | 99/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 7.87% | 55.53% | 85.18% | 75/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 4.25% | 56.83% | 72.06% | 87/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.47% | 53.42% | -48% | 63/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 4.75% | 109.33% | -6.13% | 110/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 5.06% | 321.67% | 86.72% | 67/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 2.71% | 1142.31% | 68.32% | 91/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 1.61% | 89.41% | 103.16% | 49/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | -50.92% | -3685.92% | -4343.33% | 119/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 1.2% | -43.66% | 561.54% | 62/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | -0.26% | -766.67% | -130.59% | 72/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 0.85% | 157.58% | -40.14% | 46/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 1.42% | -60.88% | -33.33% | 98/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 2.13% | -40.67% | 7200% | 52/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | -0.03% | -102.21% | -109.09% | 57/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 0.33% | -44.07% | -90.91% | 50/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 3.63% | -40.98% | 1.11% | 88/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 3.59% | -30.43% | 163.97% | 41/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 1.36% | -9.33% | 130.51% | 52/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 0.59% | -58.74% | -90.41% | 41/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 6.15% | -36.14% | 19.19% | 67/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 5.16% | 0.39% | 244% | 30/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 1.5% | -44.24% | 4.9% | 46/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 1.43% | 1.42% | -85.15% | 25/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |